{"id":"https://openalex.org/W1983294393","doi":"https://doi.org/10.1021/ml100227q","title":"Benzofuran Derivatives as Potent, Orally Active S1P1 Receptor Agonists: A Preclinical Lead Molecule for MS","display_name":"Benzofuran Derivatives as Potent, Orally Active S1P1 Receptor Agonists: A Preclinical Lead Molecule for MS","publication_year":2010,"publication_date":"2010-11-09","ids":{"openalex":"https://openalex.org/W1983294393","doi":"https://doi.org/10.1021/ml100227q","mag":"1983294393","pmid":"https://pubmed.ncbi.nlm.nih.gov/24900286","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4017978"},"language":"en","primary_location":{"id":"doi:10.1021/ml100227q","doi":"https://doi.org/10.1021/ml100227q","is_oa":false,"landing_page_url":"https://doi.org/10.1021/ml100227q","pdf_url":null,"source":{"id":"https://openalex.org/S191852912","display_name":"ACS Medicinal Chemistry Letters","issn_l":"1948-5875","issn":["1948-5875"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","jufo-1","ki-jl-1","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACS Medicinal Chemistry Letters","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4017978","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Ashis K. Saha","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210123771","display_name":"Epix Pharmaceuticals (United States)","ror":"https://ror.org/03455bm37","country_code":"US","type":"company","lineage":["https://openalex.org/I4210123771"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ashis K. Saha","raw_affiliation_strings":["EPIX Pharmaceuticals Inc., 167 Worcester Street, Suite 201, Wellesley Hills, Massachusetts 02481, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EPIX Pharmaceuticals Inc., 167 Worcester Street, Suite 201, Wellesley Hills, Massachusetts 02481, United States","institution_ids":["https://openalex.org/I4210123771"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069183135","display_name":"Yu Xiang","orcid":"https://orcid.org/0000-0003-3894-8756","observed_orcids":["https://orcid.org/0000-0003-3894-8756"]},"institutions":[{"id":"https://openalex.org/I4210123771","display_name":"Epix Pharmaceuticals (United States)","ror":"https://ror.org/03455bm37","country_code":"US","type":"company","lineage":["https://openalex.org/I4210123771"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiang Yu","raw_affiliation_strings":["EPIX Pharmaceuticals Inc., 167 Worcester Street, Suite 201, Wellesley Hills, Massachusetts 02481, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EPIX Pharmaceuticals Inc., 167 Worcester Street, Suite 201, Wellesley Hills, Massachusetts 02481, United States","institution_ids":["https://openalex.org/I4210123771"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082860873","display_name":"Jian Lin","orcid":"https://orcid.org/0000-0003-0455-9736","observed_orcids":["https://orcid.org/0000-0003-0455-9736"]},"institutions":[{"id":"https://openalex.org/I4210123771","display_name":"Epix Pharmaceuticals (United States)","ror":"https://ror.org/03455bm37","country_code":"US","type":"company","lineage":["https://openalex.org/I4210123771"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jian Lin","raw_affiliation_strings":["EPIX Pharmaceuticals Inc., 167 Worcester Street, Suite 201, Wellesley Hills, Massachusetts 02481, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EPIX Pharmaceuticals Inc., 167 Worcester Street, Suite 201, Wellesley Hills, Massachusetts 02481, United States","institution_ids":["https://openalex.org/I4210123771"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054154878","display_name":"Mercedes Lobera","orcid":"https://orcid.org/0000-0003-0803-1285","observed_orcids":["https://orcid.org/0000-0003-0803-1285"]},"institutions":[{"id":"https://openalex.org/I4210123771","display_name":"Epix Pharmaceuticals (United States)","ror":"https://ror.org/03455bm37","country_code":"US","type":"company","lineage":["https://openalex.org/I4210123771"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mercedes Lobera","raw_affiliation_strings":["EPIX Pharmaceuticals Inc., 167 Worcester Street, Suite 201, Wellesley Hills, Massachusetts 02481, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EPIX Pharmaceuticals Inc., 167 Worcester Street, Suite 201, Wellesley Hills, Massachusetts 02481, United States","institution_ids":["https://openalex.org/I4210123771"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070646575","display_name":"Anurag Sharadendu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210123771","display_name":"Epix Pharmaceuticals (United States)","ror":"https://ror.org/03455bm37","country_code":"US","type":"company","lineage":["https://openalex.org/I4210123771"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anurag Sharadendu","raw_affiliation_strings":["EPIX Pharmaceuticals Inc., 167 Worcester Street, Suite 201, Wellesley Hills, Massachusetts 02481, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EPIX Pharmaceuticals Inc., 167 Worcester Street, Suite 201, Wellesley Hills, Massachusetts 02481, United States","institution_ids":["https://openalex.org/I4210123771"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005511548","display_name":"Srinivas Chereku","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210123771","display_name":"Epix Pharmaceuticals (United States)","ror":"https://ror.org/03455bm37","country_code":"US","type":"company","lineage":["https://openalex.org/I4210123771"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Srinivas Chereku","raw_affiliation_strings":["EPIX Pharmaceuticals Inc., 167 Worcester Street, Suite 201, Wellesley Hills, Massachusetts 02481, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EPIX Pharmaceuticals Inc., 167 Worcester Street, Suite 201, Wellesley Hills, Massachusetts 02481, United States","institution_ids":["https://openalex.org/I4210123771"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039668013","display_name":"Nili C. Schutz","orcid":"https://orcid.org/0009-0009-6089-1179","observed_orcids":["https://orcid.org/0009-0009-6089-1179"]},"institutions":[{"id":"https://openalex.org/I4210123771","display_name":"Epix Pharmaceuticals (United States)","ror":"https://ror.org/03455bm37","country_code":"US","type":"company","lineage":["https://openalex.org/I4210123771"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nili Schutz","raw_affiliation_strings":["EPIX Pharmaceuticals Inc., 167 Worcester Street, Suite 201, Wellesley Hills, Massachusetts 02481, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EPIX Pharmaceuticals Inc., 167 Worcester Street, Suite 201, Wellesley Hills, Massachusetts 02481, United States","institution_ids":["https://openalex.org/I4210123771"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020548388","display_name":"Dalia Segal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210123771","display_name":"Epix Pharmaceuticals (United States)","ror":"https://ror.org/03455bm37","country_code":"US","type":"company","lineage":["https://openalex.org/I4210123771"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dalia Segal","raw_affiliation_strings":["EPIX Pharmaceuticals Inc., 167 Worcester Street, Suite 201, Wellesley Hills, Massachusetts 02481, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EPIX Pharmaceuticals Inc., 167 Worcester Street, Suite 201, Wellesley Hills, Massachusetts 02481, United States","institution_ids":["https://openalex.org/I4210123771"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027640751","display_name":"Yael Marantz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210123771","display_name":"Epix Pharmaceuticals (United States)","ror":"https://ror.org/03455bm37","country_code":"US","type":"company","lineage":["https://openalex.org/I4210123771"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yael Marantz","raw_affiliation_strings":["EPIX Pharmaceuticals Inc., 167 Worcester Street, Suite 201, Wellesley Hills, Massachusetts 02481, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EPIX Pharmaceuticals Inc., 167 Worcester Street, Suite 201, Wellesley Hills, Massachusetts 02481, United States","institution_ids":["https://openalex.org/I4210123771"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017267359","display_name":"Dilara McCauley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210123771","display_name":"Epix Pharmaceuticals (United States)","ror":"https://ror.org/03455bm37","country_code":"US","type":"company","lineage":["https://openalex.org/I4210123771"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dilara McCauley","raw_affiliation_strings":["EPIX Pharmaceuticals Inc., 167 Worcester Street, Suite 201, Wellesley Hills, Massachusetts 02481, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EPIX Pharmaceuticals Inc., 167 Worcester Street, Suite 201, Wellesley Hills, Massachusetts 02481, United States","institution_ids":["https://openalex.org/I4210123771"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057627163","display_name":"Scot C. Middleton","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Scot Middleton","raw_affiliation_strings":["Inflammation Research"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inflammation Research","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089449965","display_name":"Jerry Siu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jerry Siu","raw_affiliation_strings":["Inflammation Research"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inflammation Research","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025704103","display_name":"Roland W. B\u00fcrli","orcid":"https://orcid.org/0000-0001-7377-7628","observed_orcids":["https://orcid.org/0000-0001-7377-7628"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Roland W. B\u00fcrli","raw_affiliation_strings":["Departments of Medicinal Chemistry"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicinal Chemistry","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017627969","display_name":"Janet Buys","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Janet Buys","raw_affiliation_strings":["Comparative Biology and Safety Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Comparative Biology and Safety Sciences","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032502043","display_name":"Michelle J. Horner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michelle Horner","raw_affiliation_strings":["Comparative Biology and Safety Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Comparative Biology and Safety Sciences","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028937676","display_name":"Kevin L. Salyers","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kevin Salyers","raw_affiliation_strings":["Pharmacokinetics and Drug Metabolism"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacokinetics and Drug Metabolism","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023817049","display_name":"Michael L. Schrag","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Schrag","raw_affiliation_strings":["Pharmacokinetics and Drug Metabolism"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacokinetics and Drug Metabolism","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001580477","display_name":"Hugo M. Vargas","orcid":"https://orcid.org/0000-0001-9447-3164","observed_orcids":["https://orcid.org/0000-0001-9447-3164"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hugo M. Vargas","raw_affiliation_strings":["Comparative Biology and Safety Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Comparative Biology and Safety Sciences","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100462099","display_name":"Yang Y. Xu","orcid":"https://orcid.org/0000-0003-4643-2098","observed_orcids":["https://orcid.org/0000-0003-4643-2098"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yang Xu","raw_affiliation_strings":["Pharmacokinetics and Drug Metabolism"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacokinetics and Drug Metabolism","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041195248","display_name":"Michele E. McElvain","orcid":"https://orcid.org/0000-0003-0661-0312","observed_orcids":["https://orcid.org/0000-0003-0661-0312"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michele McElvain","raw_affiliation_strings":["Molecular Pharmacology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Pharmacology","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5013434423","display_name":"Han Xu","orcid":"https://orcid.org/0000-0002-1977-1046","observed_orcids":["https://orcid.org/0000-0002-1977-1046"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Han Xu","raw_affiliation_strings":["Molecular Pharmacology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Pharmacology","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210123771"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":1.9115,"has_fulltext":false,"cited_by_count":38,"citation_normalized_percentile":{"value":0.85058568,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"2","issue":"2","first_page":"97","last_page":"101"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11308","display_name":"Sphingolipid Metabolism and Signaling","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11308","display_name":"Sphingolipid Metabolism and Signaling","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/benzofuran-derivatives","display_name":"benzofuran derivatives","score":0.8370000123977661},{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.7549999952316284},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.7139999866485596},{"id":"https://openalex.org/keywords/adme-properties","display_name":"ADME properties","score":0.7319999933242798},{"id":"https://openalex.org/keywords/lymphodepletion","display_name":"lymphocyte depletion","score":0.6069999933242798},{"id":"https://openalex.org/keywords/experimental-autoimmune-encephalomyelitis","display_name":"experimental autoimmune encephalomyelitis","score":0.8960000276565552}],"concepts":[{"id":"https://openalex.org/C2776589655","wikidata":"https://www.wikidata.org/wiki/Q410089","display_name":"Benzofuran","level":2,"score":0.7924968600273132},{"id":"https://openalex.org/C3017990168","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Orally active","level":3,"score":0.6914587020874023},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6558129787445068},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.558619499206543},{"id":"https://openalex.org/C2777752112","wikidata":"https://www.wikidata.org/wiki/Q903238","display_name":"Lead compound","level":3,"score":0.48808062076568604},{"id":"https://openalex.org/C103697762","wikidata":"https://www.wikidata.org/wiki/Q4112105","display_name":"Virtual screening","level":3,"score":0.486723929643631},{"id":"https://openalex.org/C2777093003","wikidata":"https://www.wikidata.org/wiki/Q6508345","display_name":"Lead (geology)","level":2,"score":0.4835388660430908},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.451272189617157},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.42888760566711426},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3685190975666046},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.31803056597709656},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.23086708784103394},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.20126289129257202},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.15876370668411255},{"id":"https://openalex.org/C56173144","wikidata":"https://www.wikidata.org/wiki/Q1539893","display_name":"Pharmacophore","level":2,"score":0.13293546438217163},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.10929954051971436},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1021/ml100227q","doi":"https://doi.org/10.1021/ml100227q","is_oa":false,"landing_page_url":"https://doi.org/10.1021/ml100227q","pdf_url":null,"source":{"id":"https://openalex.org/S191852912","display_name":"ACS Medicinal Chemistry Letters","issn_l":"1948-5875","issn":["1948-5875"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","jufo-1","ki-jl-1","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACS Medicinal Chemistry Letters","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3020075","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4017978","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:24900286","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24900286","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACS medicinal chemistry letters","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4017978","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4017978/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACS Med Chem Lett","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:3020075","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4017978","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W1538324889","https://openalex.org/W1966967483","https://openalex.org/W1969141508","https://openalex.org/W2004680059","https://openalex.org/W2007541166","https://openalex.org/W2026657768","https://openalex.org/W2048528085","https://openalex.org/W2059921365","https://openalex.org/W2076293584","https://openalex.org/W2078534481","https://openalex.org/W2100663911","https://openalex.org/W2104948944","https://openalex.org/W2105192692","https://openalex.org/W2139046470","https://openalex.org/W2147760936","https://openalex.org/W2151340435","https://openalex.org/W2153518194"],"related_works":["https://openalex.org/W2016856873","https://openalex.org/W2322355155","https://openalex.org/W2011623666","https://openalex.org/W4210675392","https://openalex.org/W2004412820","https://openalex.org/W1975171689","https://openalex.org/W2320244885","https://openalex.org/W1969141508","https://openalex.org/W2292627950","https://openalex.org/W1972748647"],"abstract_inverted_index":{"We":[0],"have":[1],"discovered":[2],"novel":[3],"benzofuran-based":[4],"S1P1":[5,21],"agonists":[6],"with":[7,23],"excellent":[8,37],"in":[9,32,59],"vitro":[10,33],"potency":[11],"and":[12,36,56],"selectivity.":[13],"1-((4-(5-Benzylbenzofuran-2-yl)-3-fluorophenyl)methyl)":[14],"azetidine-3-carboxylic":[15],"acid":[16],"(18)":[17],"is":[18],"a":[19,30,60],"potent":[20],"agonist":[22],">1000\u00d7":[24],"selectivity":[25],"over":[26],"S1P3.":[27],"It":[28],"demonstrated":[29,57],"good":[31],"ADME":[34],"profile":[35],"oral":[38],"bioavailability":[39],"across":[40],"species.":[41],"Dosed":[42],"orally":[43],"at":[44],"0.3":[45],"mg/kg,":[46],"18":[47],"significantly":[48],"reduced":[49],"blood":[50],"lymphocyte":[51],"counts":[52],"24":[53],"h":[54],"postdose":[55],"efficacy":[58],"mouse":[61],"EAE":[62],"model":[63],"of":[64],"relapsing":[65],"MS.":[66]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}